UMediC Q4 Revenue Up 52% to RM18.7mil, Full-Year Revenue Rose 20.8%

UMediC Group Bhd's Q4 revenue surged 52.1% YoY to RM18.7mil, driven by higher contributions from its marketing and distribution segment. Gross profit reached RM7.1mil, while profit before tax and net profit were RM3mil and RM1.9mil, respectively. For FY22, revenue rose 20.8% to RM58.7mil, and gross profit increased 11.7% to RM25mil. The company expects its expanded manufacturing capabilities and growing exposure to specialized healthcare segments to support its next phase of growth.